Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer : Physician’s Choices
Joint Authors
Ishtiaq, Osama
Kumar, Shiyam
Shaikh, Asim Jamal
Raza, Sajjad
Mehboob, Maria
Source
International Journal of Breast Cancer
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-12-09
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
The choice of adjuvant hormonal therapy in postmenopausal women with hormone receptor positive breast cancer has remained a matter of controversy and debate.
The variety of agents is available, with each claiming to be superior.
This clinical survey was undertaken to get an impression of the physician’s first choice of therapy in an attempt to find out what questions still need to be answered in the making of “standard of care.” A web-based clinical survey was sent to the cancer physicians around the world, and 182 physicians responded to the survey.
Most were medical oncologists in a tertiary care hospital.
36.3% preferred Anastrozole, 35.2% Tamoxifen, and 22.2% Letrozole as their first choice.
Data support (67.8%) and safety concerns (30%) were given as the main reasons for the choice, 63.7% switched their therapy, and 24% had to switch because of side effects.
73.6% used 5 years of adjuvant hormonal therapy, 6.6% for 7 years, and 4.4% for 10 years.
61.5% follow their patients 3 times monthly, and 73.2% used laboratory and radiological assessment at each followup.
Conclusion.
Physicians show disagreement over the choice and duration of hormonal therapy in this patient population.
Clinical trials leading to firm recommendations to set standards from which patients benefit the most are needed.
American Psychological Association (APA)
Shaikh, Asim Jamal& Kumar, Shiyam& Raza, Sajjad& Mehboob, Maria& Ishtiaq, Osama. 2012. Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer : Physician’s Choices. International Journal of Breast Cancer،Vol. 2012, no. 2012, pp.1-5.
https://search.emarefa.net/detail/BIM-503148
Modern Language Association (MLA)
Shaikh, Asim Jamal…[et al.]. Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer : Physician’s Choices. International Journal of Breast Cancer No. 2012 (2012), pp.1-5.
https://search.emarefa.net/detail/BIM-503148
American Medical Association (AMA)
Shaikh, Asim Jamal& Kumar, Shiyam& Raza, Sajjad& Mehboob, Maria& Ishtiaq, Osama. Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer : Physician’s Choices. International Journal of Breast Cancer. 2012. Vol. 2012, no. 2012, pp.1-5.
https://search.emarefa.net/detail/BIM-503148
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-503148